| A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations (NCT07514858) | H. Lundbeck A/S | 2026-06-30 |
| A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD) (NCT07513441) | H. Lundbeck A/S | 2026-05-26 |
| A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have Narcolepsy (NCT07613710) | H. Lundbeck A/S | 2025-06-13 |
| A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA) (NCT06706622) | H. Lundbeck A/S | 2024-12-03 |
| A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease (NCT06557850) | H. Lundbeck A/S | 2024-09-19 |
| A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine (NCT06578585) | H. Lundbeck A/S | 2024-09-13 |
| A Trial of Lu AG13909 in Adult Participants With Cushing's Disease (NCT06471829) | H. Lundbeck A/S | 2024-06-19 |
| A Study Investigating the Movement of Lu AF28996 Into, Through, and Out of the Body of Healthy Men (NCT06337110) | H. Lundbeck A/S | 2024-04-10 |
| A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments (NCT06323928) | H. Lundbeck A/S | 2024-04-01 |
| A Trial Investigating Lu AF82422 in Healthy Chinese and Caucasian Adults (NCT06258720) | H. Lundbeck A/S | 2024-03-18 |
| A Trial Investigating Lu AF28996 in Healthy Adult Participants (NCT06277609) | H. Lundbeck A/S | 2024-02-27 |
| A Trial Investigating the Pain-relieving Properties of Lu AG06474 in Healthy Adult Participants (NCT06077786) | H. Lundbeck A/S | 2023-10-13 |
| A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD) (NCT06004180) | H. Lundbeck A/S | 2023-09-12 |
| A Study Investigating Lu AG06474 in Healthy Young Participants (NCT05943327) | H. Lundbeck A/S | 2023-06-28 |
| A Study of Eptinezumab in Pediatric Participants With Episodic Migraine (NCT05897320) | H. Lundbeck A/S | 2023-06-08 |
| A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia (NCT05669950) | H. Lundbeck A/S | 2022-12-19 |
| A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache (NCT05452239) | H. Lundbeck A/S | 2022-07-01 |
| Observational Study in Multiple System Atrophy (NCT05453058) | H. Lundbeck A/S | 2022-06-25 |
| A Brain Imaging PET Study of [11C]-Lu AF88370 in Healthy Adult Male Participants (NCT05320302) | H. Lundbeck A/S | 2022-03-31 |
| A Brain Imaging PET Study of [11C]-Lu AF90103 in Healthy Adult Male Participants (NCT05306366) | H. Lundbeck A/S | 2022-03-23 |
| A Study Investigating the Movement of Lu AG09222 Into, Through, and Out of the Body of Healthy Caucasian, Chinese, and Japanese Participants (NCT05304910) | H. Lundbeck A/S | 2022-03-18 |
| A Study Investigating Lu AG22515 in Healthy Adults (NCT05136053) | H. Lundbeck A/S | 2022-03-18 |
| Real World Effectiveness of Eptinezumab in Participants With Migraine (NCT05284019) | H. Lundbeck A/S | 2022-03-04 |
| Binding and Effects of Lu AG06466 in the Brain of Healthy Men (NCT05219838) | H. Lundbeck A/S | 2022-01-18 |
| A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine (NCT05164172) | H. Lundbeck A/S | 2021-12-01 |
| Safety and Tolerability Study of Lu AG06466 in Healthy Young Japanese and Caucasian Participants (NCT05177029) | H. Lundbeck A/S | 2021-11-26 |
| A Study of Lu AF82422 in Participants With Multiple System Atrophy (NCT05104476) | H. Lundbeck A/S | 2021-11-16 |
| A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments (NCT05133323) | H. Lundbeck A/S | 2021-11-11 |
| A Trial to Learn More About Repeated Monthly Injections of Lu AG09222 in Participants With Allergies to Grass Pollen (NCT05126316) | H. Lundbeck A/S | 2021-11-01 |
| A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy (NCT05081518) | H. Lundbeck A/S | 2021-09-29 |
| A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines (NCT05074459) | H. Lundbeck A/S | 2021-09-27 |
| Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan (NCT05064371) | H. Lundbeck A/S | 2021-09-21 |
| A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH) (NCT05064397) | H. Lundbeck A/S | 2021-09-17 |
| A Study to Evaluate a New Tablet Formulation of Lu AG06466 in Healthy Participants (NCT05028673) | H. Lundbeck A/S | 2021-08-23 |
| Vortioxetine to Prevent Return of Symptoms in Children With Depression (NCT05014919) | H. Lundbeck A/S | 2021-08-10 |
| Safety and Tolerability of Lu AG06474 in Healthy Young Men (NCT05003687) | H. Lundbeck A/S | 2021-08-04 |
| A Single Dose Study of Lu AG09222 in a Headache Model With Healthy Subjects (NCT04976309) | H. Lundbeck A/S | 2021-07-15 |
| A Study to Evaluate Lu AG06466 in Participants With Fibromyalgia (NCT04974359) | H. Lundbeck A/S | 2021-06-24 |
| Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine (NCT04921384) | H. Lundbeck A/S | 2021-05-29 |
| A Study to Evaluate Lu AF90103 in Healthy Men (NCT04940949) | H. Lundbeck A/S | 2021-05-26 |
| Safety, Tolerability and Pharmacokinetics of Eptinezumab in Healthy Chinese Subjects (NCT05045781) | H. Lundbeck A/S | 2021-04-20 |
| Eptinezumab in Adults With Migraine and Medication Overuse Headache (NCT04772742) | H. Lundbeck A/S | 2021-02-17 |
| Eptinezumab in Participants With Episodic Cluster Headache (NCT04688775) | H. Lundbeck A/S | 2020-12-23 |
| Drug Drug Interaction Study With Lu AG06466 in Young Healthy Men (NCT04713254) | H. Lundbeck A/S | 2020-12-08 |
| Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD) (NCT04597450) | H. Lundbeck A/S | 2020-09-30 |
| A Study in Healthy Men to Investigate Uptake and Distribution of Lu AF88434 in the Brain (NCT04538014) | H. Lundbeck A/S | 2020-08-24 |
| A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab (NCT04537429) | H. Lundbeck A/S | 2020-08-04 |
| Safety and Tolerability of Lu AG06479 in Healthy Young Men (NCT04473651) | H. Lundbeck A/S | 2020-07-09 |
| Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression (NCT04448431) | H. Lundbeck A/S | 2020-06-18 |
| A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments (NCT04418765) | H. Lundbeck A/S | 2020-06-01 |
| Binding of Lu AG06466 in the Brain in Healthy Men (NCT04419636) | H. Lundbeck A/S | 2020-05-29 |
| Study That Evaluates the Effect of CYP3A4 Inhibition on Lu AG06466 in Healthy Men and Women (NCT04405323) | H. Lundbeck A/S | 2020-05-20 |
| Eptinezumab in Healthy Japanese Subjects (NCT04336449) | H. Lundbeck A/S | 2020-04-01 |
| Vortioxetine in Patients With Depression and Early Dementia (NCT04294654) | H. Lundbeck A/S | 2020-02-28 |
| Lu AF28996 in Participants With Parkinson's Disease (PD) (NCT04291859) | H. Lundbeck A/S | 2020-02-26 |
| Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in India (NCT04288895) | H. Lundbeck A/S | 2020-02-20 |
| Effects of Repeated Doses of Foliglurax on Drug Metabolizing Enzymes in Healthy Subjects (NCT04275115) | H. Lundbeck A/S | 2020-02-10 |
| Study Investigating Effects of Foliglurax in Patients With Parkinson's Disease (PD) and Healthy Subjects (NCT04322227) | H. Lundbeck A/S | 2020-01-23 |
| Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD) (NCT04220996) | H. Lundbeck A/S | 2019-12-27 |
| Safety and Tolerability of Lu AF95245 in Healthy Young Men (NCT04199585) | H. Lundbeck A/S | 2019-12-10 |
| Binding of Foliglurax to Regions in the Brain in Healthy Participants and in Patients With Parkinson's Disease (PD) (NCT04175132) | H. Lundbeck A/S | 2019-11-12 |
| A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine (NCT04152083) | H. Lundbeck A/S | 2019-11-07 |
| Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease (NCT04149860) | H. Lundbeck A/S | 2019-09-27 |
| Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman (NCT04197349) | H. Lundbeck A/S | 2019-09-24 |
| A Study Investigating Tablet Formulations of Lu AF11167 in Healthy Subjects (NCT04104503) | H. Lundbeck A/S | 2019-09-17 |
| Study Investigating the Safety and Tolerability of Lu AF88434 in Healthy Young Men (NCT04082325) | H. Lundbeck A/S | 2019-07-23 |
| What the Body Does to Foliglurax in Healthy Volunteers (NCT04002895) | H. Lundbeck A/S | 2019-06-27 |
| Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative Symptoms (NCT03929497) | H. Lundbeck A/S | 2019-04-22 |
| A Study Investigating Formulations of Vortioxetine Applied Under the Tongue in Healthy Subjects (NCT03884491) | H. Lundbeck A/S | 2019-03-18 |
| Study With Vortioxetine on Emotional Functioning in Patients With Depression (NCT03835715) | H. Lundbeck A/S | 2019-02-05 |
| A Positron Emission Tomography (PET) Study to Examine the Brain Binding Properties of a Novel Radioactive Compound [11C]-PXT012253 in Healthy Subjects (NCT03826134) | H. Lundbeck A/S | 2019-01-17 |
| Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to AD (NCT03819699) | H. Lundbeck A/S | 2018-12-12 |
| Vortioxetine Intravenous Infusion at Initiation of Oral Treatment With Vortioxetine in Patients With Depression (NCT03766867) | H. Lundbeck A/S | 2018-12-03 |
| Study With Lu AF35700 in Healthy Men and Women in Fasting and Fed State (NCT03670082) | H. Lundbeck A/S | 2018-09-05 |
| Study in Healthy Subjects to Compare Two Tablet Formulations of Memantine (Ebixa®) in Fasted and Fed Conditions (NCT03670095) | H. Lundbeck A/S | 2018-08-28 |
| A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD) (NCT03668405) | H. Lundbeck A/S | 2018-06-26 |
| Single Dose of Lu AF28996 to Healthy Young Men (NCT03565094) | H. Lundbeck A/S | 2018-05-29 |
| Bioequivalence Study to Compare Two Formulations of Deanxit® (NCT03472651) | H. Lundbeck A/S | 2018-05-07 |
| Single Ascending Dose Study of Lu AF76432 in Healthy Young Men (NCT03531229) | H. Lundbeck A/S | 2018-04-17 |
| Bioequivalence Study of Lu AF35700 (NCT03394482) | H. Lundbeck A/S | 2018-01-03 |
| Real-life Effectiveness of Vortioxetine in Depression (NCT03555136) | H. Lundbeck A/S | 2017-11-17 |
| Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease (NCT03307993) | H. Lundbeck A/S | 2017-09-22 |